Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.06 USD | -3.37% | -5.71% | +0.25% |
01/04 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
01/04 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.25% | 921M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Needham Raises Liquidia's Price Target to $16 From $12, Maintains Buy Rating